Journal article

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML

Susan Branford, David T Yeung, David M Ross, Jodi A Prime, Chani R Field, Haley K Altamura, Alexandra L Yeoman, Jasmina Georgievski, Bronte A Jamison, Stuart Phillis, Brad Sullivan, Nancy E Briggs, Mark Hertzberg, John F Seymour, John Reynolds, Timothy P Hughes

Blood | AMER SOC HEMATOLOGY | Published : 2013